Consolidated Statements of Changes in Stockholders' Equity (Deficiency) (Parenthetical) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Consolidated Statements of Changes in Stockholders' Equity (Deficiency) | ||
| Gross proceeds from initial public offering | $ 10,169,027 | $ 12,503,750 |
| Issuance costs on initial public offering | 381,878 | 1,898,005 |
| Gross proceeds from Issuance of common stock and warrants in follow-on public offering | 20,699,992 | |
| Issuance costs on follow-on public offering | $ 1,810,080 | |
| Gross proceeds upon exercise of warrants | 10,169,027 | |
| Issuance costs upon exercise of warrants | $ 465,397 | |
| X | ||||||||||
- Definition The gross cash inflow associated with the amount received from entity's first offering of stock to the public, before deduction of offering costs. No definition available.
|
| X | ||||||||||
- Definition The gross cash inflow from issuance of common stock and warrants in follow-on public offering No definition available.
|
| X | ||||||||||
- Definition The gross cash inflow associated with the exercise of warrwnts, before deduction of offering costs. No definition available.
|
| X | ||||||||||
- Definition The amount of payments of issuance costs upon exercise of warrants. No definition available.
|
| X | ||||||||||
- Definition Payments of Issuance Of Follow On Public Offering No definition available.
|
| X | ||||||||||
- Definition The cash outflow for loan and debt issuance costs. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|